Introduction
The Drug Enforcement Administration (DEA) has announced a draft notice of intent to temporarily ban 7-OH, a component of kratom with opioid-like effects, in a move that could significantly impact the mainstream kratom industry. The ban would apply to products that contain a specific threshold of 7-OH and would be in effect for two years, with the potential to extend for a third. The DEA claims that 7-OH presents severe risks to public health, including tolerance, dependence, and addiction. This move is a major win for the mainstream kratom industry, which has been fighting 7-OH with the backing of government officials, including President Donald Trump.
Kratom Overview
Kratom is a Southeast Asian plant with analgesic and antidepressant properties when taken in low doses. Natural kratom contains trace amounts of 7-OH. However, in recent years, there has been an explosion in the production and sales of unregulated 7-OH products, which can be much more potent than natural kratom products.
DEA's Reasoning
The agency's reasoning is based on the fact that 7-OH can activate mu-opioid receptors in the brain, which can lead to potentially addictive qualities.
Public Health Concerns
However, the DEA's proposed ban has also drawn criticism from some in the kratom industry, who argue that there is no scientific basis for the ban. The DEA's proposed ban would take effect after a 30-day public comment period.
Kratom Industry Response
The DEA's proposed ban has been met with mixed reactions from the kratom industry. The American Kratom Association, a lobbying group for the kratom industry, has welcomed the proposed ban, stating that it should end the debate. The Holistic Alternative Recovery Trust, a 7-OH advocacy group, has argued that there is no scientific basis for the ban, and has stated that hundreds of thousands of consumers are eager to share how 7-OH has helped them manage pain, return to work, care for their families, and reclaim their lives.
Conclusion
The DEA's proposed ban on 7-OH is a significant development in the kratom industry, and will have far-reaching implications for the industry and its consumers. The DEA's proposed ban has been met with mixed reactions from the kratom industry, and will likely be subject to further debate and discussion in the coming months.

Comments